Published in Dis Model Mech on November 01, 2013
Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell (2015) 1.52
Metabolic shifts in residual breast cancer drive tumor recurrence. J Clin Invest (2017) 1.38
Lipid metabolic reprogramming in cancer cells. Oncogenesis (2016) 1.16
mTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol Metab (2014) 1.05
Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging. Sci Rep (2014) 0.95
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats. Proc Natl Acad Sci U S A (2016) 0.91
The transcriptional response to tumorigenic polarity loss in Drosophila. Elife (2015) 0.89
Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression. Neoplasia (2015) 0.85
Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol Metab (2015) 0.84
Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation. Oncotarget (2016) 0.83
Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS One (2015) 0.82
Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment. Oncotarget (2015) 0.82
Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems. Am J Cancer Res (2016) 0.81
DECODE: an integrated differential co-expression and differential expression analysis of gene expression data. BMC Bioinformatics (2015) 0.81
Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses. J Biol Chem (2015) 0.81
Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment. Philos Trans R Soc Lond B Biol Sci (2018) 0.80
Progress toward overcoming hypoxia-induced resistance to solid tumor therapy. Cancer Manag Res (2015) 0.80
p53 attenuates AKT signaling by modulating membrane phospholipid composition. Oncotarget (2015) 0.79
Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7. Evid Based Complement Alternat Med (2015) 0.79
Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration. Oncotarget (2015) 0.79
Lipid biomarkers and long-term risk of cancer in the Women's Health Study. Am J Clin Nutr (2016) 0.79
Reconstruction of Tissue-Specific Metabolic Networks Using CORDA. PLoS Comput Biol (2016) 0.79
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism. Biochem Soc Trans (2015) 0.78
Pheochromocytoma: The First Metabolic Endocrine Cancer. Clin Cancer Res (2016) 0.78
Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells. Oncogene (2015) 0.78
Nuclear localized LSR, a novel regulator of breast cancer behavior and tumorigenesis. Mol Cancer Res (2016) 0.78
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget (2015) 0.77
Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis. Oncotarget (2016) 0.77
Maf1, A New PTEN Target Linking RNA and Lipid Metabolism. Trends Endocrinol Metab (2016) 0.77
Biochemical characterization of the interaction between HspA1A and phospholipids. Cell Stress Chaperones (2015) 0.77
Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. Oncotarget (2016) 0.77
Whole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse Model. PLoS One (2016) 0.77
Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression. Obes Rev (2016) 0.77
Mammalian phospholipid homeostasis: evidence that membrane curvature elastic stress drives homeoviscous adaptation in vivo. J R Soc Interface (2016) 0.77
A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis. Oncotarget (2016) 0.76
Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines. Cancer Biol Ther (2015) 0.76
Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia. Int J Mol Sci (2016) 0.76
Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry. Oncotarget (2017) 0.75
Diet and Pancreatic Cancer Prevention. Cancers (Basel) (2015) 0.75
Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer. Sci Rep (2017) 0.75
Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients. J Thorac Dis (2016) 0.75
Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma. Chin J Cancer Res (2016) 0.75
Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics. J Cancer Prev (2016) 0.75
Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism. J Lipid Res (2015) 0.75
Lipidomic Profiling of Lung Pleural Effusion Identifies Unique Metabotype for EGFR Mutants in Non-Small Cell Lung Cancer. Sci Rep (2016) 0.75
Membrane Glycolipids Content Variety in Gastrointestinal Tumors and Transplantable Hepatomas in Mice. Med Sci Monit Basic Res (2016) 0.75
Proteomic profiling of retinoblastoma by high resolution mass spectrometry. Clin Proteomics (2016) 0.75
Imaging cervical cytology with scanning near-field optical microscopy (SNOM) coupled with an IR-FEL. Sci Rep (2016) 0.75
Regulation of lipid synthesis by the RNA helicase Mov10 controls Wnt5a production. Oncogenesis (2015) 0.75
A Molecular Probe for the Detection of Polar Lipids in Live Cells. PLoS One (2016) 0.75
Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver. Biochim Biophys Acta (2016) 0.75
New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells. Front Endocrinol (Lausanne) (2016) 0.75
Microfluidic sampling system for tissue analytics. Biomicrofluidics (2015) 0.75
Pancreatic cancer from bench to bedside: molecular pathways and treatment options. Ann Transl Med (2016) 0.75
Emerging Roles for Maf1 beyond the Regulation of RNA Polymerase III Activity. J Mol Biol (2015) 0.75
Dietary ω-3 Polyunsaturated Fatty Acids Inhibit Tumor Growth in Transgenic Apc(Min/+) Mice, Correlating with CB1 Receptor Up-Regulation. Int J Mol Sci (2017) 0.75
The Hippo pathway, p53 and cholesterol. Cell Cycle (2016) 0.75
CD1b-autoreactive T cells recognize phospholipid antigens and contribute to antitumor immunity against a CD1b(+) T cell lymphoma. Oncoimmunology (2016) 0.75
"Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma. PLoS One (2017) 0.75
The Stearoyl-CoA Desaturase-1 (Desat1) in Drosophila cooperated with Myc to Induce Autophagy and Growth, a Potential New Link to Tumor Survival. Genes (Basel) (2017) 0.75
Image-Based Chemical Structure Determination. Sci Rep (2017) 0.75
A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling. Oncogenesis (2017) 0.75
Significance of long chain polyunsaturated fatty acids in human health. Clin Transl Med (2017) 0.75
CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation. Proc Natl Acad Sci U S A (2017) 0.75
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34
Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol (2007) 15.30
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell (2008) 13.49
Autophagy regulates lipid metabolism. Nature (2009) 13.33
Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer (2003) 13.01
Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol (2008) 12.34
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 10.20
ATP-citrate lyase links cellular metabolism to histone acetylation. Science (2009) 8.82
Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell (2012) 8.71
Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature (2011) 7.94
ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell (2005) 7.65
Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell (2010) 7.61
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev (2011) 7.43
The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer (2003) 6.70
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab (2008) 6.60
Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 6.15
Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer (2012) 6.14
Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer (2008) 6.02
Eicosanoids and cancer. Nat Rev Cancer (2010) 5.96
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell (2010) 5.47
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A (2011) 5.24
Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol (2010) 5.03
Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev (2007) 4.91
Lipid signalling in disease. Nat Rev Mol Cell Biol (2008) 4.85
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell (2012) 4.09
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab (2011) 3.98
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem (2002) 3.53
Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A (1994) 3.50
Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab (2011) 3.49
ATP citrate lyase is an important component of cell growth and transformation. Oncogene (2005) 3.48
Lipid metabolism in cancer. FEBS J (2012) 3.42
Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care (2006) 3.09
Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities. Eur J Biochem (1989) 3.09
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev (2011) 2.97
Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci U S A (2000) 2.93
SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell (2005) 2.81
PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene (2005) 2.77
A conserved SREBP-1/phosphatidylcholine feedback circuit regulates lipogenesis in metazoans. Cell (2011) 2.75
Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci U S A (2013) 2.57
SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature (2013) 2.52
The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry (2008) 2.40
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J Biol Chem (2002) 2.36
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci Signal (2009) 2.23
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A (2003) 2.23
VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell (2012) 2.14
Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res (2011) 2.07
Greasing their way: lipid modifications determine protein association with membrane rafts. Biochemistry (2010) 2.06
M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol (2011) 2.02
Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis (2010) 2.01
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res (2008) 1.98
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One (2012) 1.93
Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res (2008) 1.92
Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol (2009) 1.88
SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol (2007) 1.87
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res (2004) 1.81
Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res (2007) 1.81
Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell (2009) 1.80
Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer (2012) 1.79
Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res (2011) 1.76
Expanding roles for SREBP in metabolism. Cell Metab (2012) 1.76
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res (2005) 1.74
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res (2012) 1.71
Dysregulation of the mevalonate pathway promotes transformation. Proc Natl Acad Sci U S A (2010) 1.71
Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab (2009) 1.69
Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res (1953) 1.64
De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res (2010) 1.59
The role of lipids in the control of autophagy. Curr Biol (2013) 1.59
Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol (2003) 1.56
Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy. Cell Metab (2011) 1.50
Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem (2010) 1.48
ATP-citrate lyase: a key player in cancer metabolism. Cancer Res (2012) 1.48
Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS One (2010) 1.46
The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care (2006) 1.43
Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS One (2009) 1.42
Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther (2010) 1.42
Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics (2006) 1.38
Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res (2011) 1.38
Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res (2001) 1.38
Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res (2011) 1.37
Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab (2013) 1.35
Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci U S A (2010) 1.35
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene (2005) 1.35
Coordination of lipid metabolism in membrane biogenesis. Annu Rev Cell Dev Biol (2009) 1.30
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One (2012) 1.29
Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One (2010) 1.24
Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity. Clin Cancer Res (2009) 1.14
Prostate cancer cell growth is modulated by adipocyte-cancer cell interaction. BJU Int (2003) 1.13
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076. Biochem J (1998) 1.13
Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res (2012) 1.13
The lipogenesis pathway as a cancer target. J Med Chem (2011) 1.12
Phospholipase signalling networks in cancer. Nat Rev Cancer (2012) 1.10
Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors. Clin Cancer Res (2008) 1.08
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas. Br J Cancer (2012) 1.07
Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells. J Biol Chem (2010) 1.04
Hypoxia and the metabolic phenotype of prostate cancer cells. Biochim Biophys Acta (2009) 1.00
Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis. Circ Res (2004) 0.99
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab (2008) 6.60
Lipid metabolism in cancer. FEBS J (2012) 3.42
Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov (2012) 3.03
Cellular fatty acid metabolism and cancer. Cell Metab (2013) 2.82
PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene (2005) 2.77
Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression. Mol Cell Biol (2007) 1.96
FOXM1 confers acquired cisplatin resistance in breast cancer cells. Mol Cancer Res (2010) 1.95
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther (2009) 1.56
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol (2009) 1.46
Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol Cell (2005) 1.34
The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression. Mol Cell Biol (2008) 1.31
Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling. Mol Syst Biol (2013) 1.24
A new player in the orchestra of cell growth: SREBP activity is regulated by mTORC1 and contributes to the regulation of cell and organ size. Biochem Soc Trans (2009) 1.24
Targeting cancer metabolism--aiming at a tumour's sweet-spot. Drug Discov Today (2011) 1.21
Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism. Cancer Metab (2013) 1.12
Antagonism between FOXO and MYC Regulates Cellular Powerhouse. Front Oncol (2013) 1.10
Direct control of caveolin-1 expression by FOXO transcription factors. Biochem J (2005) 1.02
Regulation of the SREBP transcription factors by mTORC1. Biochem Soc Trans (2011) 1.00
Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor. Mol Cell Biol (2010) 0.89
A role for the cancer-associated miR-106b~25 cluster in neuronal stem cells. Aging (Albany NY) (2011) 0.87
Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth. Cancer Discov (2013) 0.81
Linking glycogen and senescence in cancer cells. Cell Metab (2012) 0.81
Genetic ablation of S6-kinase does not prevent processing of SREBP1. Adv Enzyme Regul (2010) 0.78
Women in Metabolism: Part 3. Cell Metab (2015) 0.75